http://www.lensar.com/ascrs2015/
The LENSAR Laser System is the first femtosecond laser cataract platform
to establish a wireless integration protocol with preoperative
diagnostic devices. The company is initiating this capability with the
Cassini Corneal Shape Analyzer enabling the wireless transfer of data
from preoperative corneal measurements to the LENSAR Laser System. This
new integration eliminates potential errors that can occur from manual
entry of data from the device used in the preoperative and surgical
planning process. The integration with Cassini enables the capture of
preoperative iris registration data, and maps it to the image of the eye
obtained under the laser at procedure time, eliminating the need to
manually ink mark the eye to identify and adjust for the cyclorotation
that may occur when a patient is reclined during surgery.
"Creating an integrated technology approach to the femtosecond cataract
procedure is something we refractive cataract surgeons have been waiting
for, and it doesn't surprise me at all that LENSAR was the company to
get it done," said Jonathan Solomon, M.D. surgical/refractive director
at Solomon Eye Associates in Maryland. "I anticipate LENSAR's Streamline
will improve not only OR efficiency and patient experience during the
procedure, but may also improve outcomes by minimizing the human factor
inherent in manual data input or physically marking the eye
pre-operatively."
Additionally, for the first time, surgeons have access to an arcuate
incision planning table on the laser that includes parameters to define
the location, depth and extent of the surgeon's intended arcuate
incisions based on individual patient biometric measurements and other
factors defined by the surgeon. The arcuate incision planning capability
allows surgeons to retain their plan preferences for later use,
increasing surgical operating room efficiency.
The Streamline upgrades also introduce integrated cataract density
imaging, which automatically categorizes the cataract to a
pre-programmed, surgeon-customized fragmentation pattern depending upon
the density of the cataract and allows the surgeon to automatically
isolate fragmentation to the nucleus. This first-in-market innovation
may have a positive impact on efficiency and procedure time.
"LENSAR has given the reigns to the surgeon to make the laser-assisted
refractive cataract procedure customized to both patient and surgeon
needs," said Robert Weinstock, M.D., director of cataract and refractive
services at the Eye Institute of West Florida and The Weinstock Laser
Eye Center. "The ability to preprogram the laser just one time with a
surgeon's specific preferences for fragmentation patterns based upon an
automated cataract density analysis and customized arcuate incision
plans may increase the efficiency and accuracy for every procedure
thereafter, enhancing patient comfort and, ultimately, visual outcomes."
Streamline upgrades, including the arcuate incision planning, cataract
density imaging and customized fragmentation patterns, will be made
available to all LENSAR users. The full Streamline technology suite will
be available to practices currently using both the LENSAR Laser System
and the Cassini Corneal Shape Analyzer.
LENSAR has placed more than 140 systems with customers around the world
since its introduction in July of 2012, and the system has been used in
nearly 60,000 cataract surgery procedures.
About LENSAR, Inc.
LENSAR, Inc., is a global leader in next generation femtosecond laser
technology for refractive cataract surgery. The LENSAR Laser System
offers cataract surgeons precision, accuracy, and efficiency while
optimizing overall visual outcomes. LENSAR's proprietary Augmented
Reality™ technology - reconstructed 3-D imaging, measurement, and
guidance system - offers quick and easy patient docking and provides
high-resolution ocular images in a single scan. This technology
facilitates enhanced procedure outcomes by allowing the physician to
develop individualized treatment plans including precise laser delivery
and efficient lens fragmentation that can reduce, and potentially
eliminate, phaco energy. The LENSAR Laser System also offers the
industry's smallest laser footprint and thoughtful ergonomic design that
accommodates most operating rooms.
With the recent FDA clearance of five application upgrades, offered as
the Streamline™ upgrade, the LENSAR Laser System becomes the first to
offer automation and customization of essential steps of the refractive
cataract surgery procedure. The LENSAR Laser System, has been cleared by
the FDA for anterior capsulotomy, lens fragmentation, and corneal and
arcuate incisions. For other indications it is an investigational device
limited by U.S. law to investigational use only. For more information,
please visit www.lensar.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150401005227/en/
[ Back To Mobile World Congress's Homepage ]